Loading...
XHKG
0897
Market cap56mUSD
Dec 05, Last price  
0.39HKD
1D
0.00%
1Q
11.43%
Jan 2017
2.63%
Name

Wai Yuen Tong Medicine Holdings Ltd

Chart & Performance

D1W1MN
XHKG:0897 chart
P/E
61.80
P/S
0.59
EPS
0.01
Div Yield, %
37.69%
Shrs. gr., 5y
-1.78%
Rev. gr., 5y
3.73%
Revenues
745m
-4.92%
324,756,000381,266,000477,021,000496,151,000529,305,000639,512,000752,072,000808,517,000865,258,000831,088,000825,331,000738,440,000845,781,000751,443,000620,741,0001,108,565,0001,391,411,0001,286,428,000783,881,000745,298,000
Net income
7m
P
-106,152,0009,923,00083,382,000-345,906,00045,797,00099,133,000-226,922,000148,433,000163,374,000120,979,00025,387,000-93,303,000-115,581,00074,627,000438,548,000-375,995,000-108,912,000-20,515,000-15,356,0007,100,000
CFO
102m
-46.62%
5,073,000123,500,000-22,808,00016,864,00040,320,000-106,802,00033,724,000-9,884,00015,294,00052,787,000-115,661,000-89,867,000-76,731,000-26,633,0009,177,000358,490,000116,181,00091,578,000191,688,000102,319,000
Dividend
Aug 22, 20240.147 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Wai Yuen Tong Medicine Holdings Limited, an investment holding company, manufactures, processes, and retails traditional Chinese medicines, Western pharmaceutical products, and health food and personal products in Hong Kong, Mainland China, Macau, and internationally. The company offers Chinese medicines and health food products under the Wai Yuen Tong brand name; and Western pharmaceutical and personal care products under the Madame Pearl's and Pearl's brands. It also engages in the investment, holding, and selling of properties; provision of financial services; and agricultural produce exchange market operation. As of March 31, 2022, the company operated 63 retail stores in Hong Kong. The company was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong. Wai Yuen Tong Medicine Holdings Limited is a subsidiary of Rich Time Strategy Limited.
IPO date
Oct 31, 1997
Employees
1,941
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT